Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion type Assertion NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_head.
- NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion description "[The CCL2 variant correlated with a low transcriptional level behaves as a genetic modifier of clinical outcome for T. cruzi infection, and subjects with the CCL2 -2518AA genotype have a 4-fold greater risk of developing CCC than do those without this genotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_provenance.
- NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion evidence source_evidence_literature NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_provenance.
- NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion SIO_000772 16804844 NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_provenance.
- NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion wasDerivedFrom befree-20140225 NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_provenance.
- NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_assertion wasGeneratedBy ECO_0000203 NP212791.RAZFsta88f298riRuCcm0-wNyHzI-uFsC1bBYoqI95cUc130_provenance.